Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
BMEDvsIBBETF Comparison
iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. iShares Biotechnology ETF (IBB) is part of the US Health Care segment. BMED's top 3 sector exposures are Health Care and Consumer Discretionary. In contrast, IBB's top sector exposures are Health Care BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.44% for IBB. BMED is down -5.49% year-to-date (YTD) with +$4M in YTD flows. IBB performs better with -2.03% YTD performance, and -$197M in YTD flows. Run a side-by-side ETF comparison of BMED and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
BMED vs IBB performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BMED IBB | -6.03%-4.17% | -5.68%-2.29% | -5.49%-2.03% | +16.79%+24.51% | +27.36%+32.97% | -1.83%+6.60% |
| Flows | BMED IBB | +$1M-$42M | +$4M-$468M | +$4M-$197M | +$7M+$704M | +$4M-$1.73B | +$5M-$2.28B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BMED IBB | +15.26%+21.00% | +17.92%+23.59% | +15.51%+19.49% | +17.58%+22.11% |
| Max drawdown | BMED IBB | -10.40%-6.89% | -14.01%-17.66% | -19.76%-24.82% | -33.96%-39.75% |
| Max drawdown duration | BMED IBB | 50d50d | 113d148d | 237d377d | 1586d1611d |
BMED | IBB | |
Last sale 3/13/2026 at 1:30 PM | $28.63 | $165.51 |
| Previous close 03/12/2026 | $28.78 | $166.23 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BMED | IBB | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BMED | IBB | |
|---|---|---|
| Last price | $28.63 | $165.51 |
| 1D performance | -0.52% | -0.43% |
| AuM | $10.31 M | $7.98 B |
| E/R | 0.77% | 0.44% |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the BMED and IBB ETFs performed in 2026?
As of March 13, 2026, BMED is down -5.49% year-to-date (YTD), while IBB has lost -2.03%. That puts IBB better performer ahead so far this year.
Which ETF is attracting more investor money: BMED or IBB?
Year-to-date, the BMED ETF saw +$4M in flows, compared to -$197M for IBB.
Which ETF is more volatile: BMED or IBB?
Over the past year, BMED had a volatility of 17.92%, while IBB experienced 23.59%.
Which ETF is bigger: BMED or IBB?
As of March 13, 2026, BMED holds $10.31 M in assets under management (AUM), while IBB manages $7.98 B.
What sectors do the BMED and IBB ETFs invest in?
BMED leans toward sectors like Health Care. Meanwhile, IBB focuses on Health Care.
What are the top holdings of the BMED ETF and IBB ETF?
BMED top holdings include JOHNSON&JOHNSON, GILEAD SCIENCES and EXACT SCIENCES. IBB holds in its top three: GILEAD SCIENCES, VERTEX PHARMACEUTICALS and AMGEN-T.
Which ETF is more diversified: BMED or IBB?
BMED holds 144 securities with 38.18% of its assets in the top 15. IBB has 254 securities and a top 15 weight of 56.67%.
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
Are Biotechnology ETFs In the Midst of a Comeback?
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
Health is Wealth: A look at the Healthcare Sector
Biotech ETFs – Investing in Health Innovation
Biotech ETFs – Investing in Health Innovation
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
